State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Non-Hodgkin Lymphoma (Late Stage^), 2018-2022

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

Iowa⁷

• Rate : The incidence rate is 15.3 with a 95% confidence interval from 14.8 to 15.9 and 613 average annual cases over 2018-2022.
• CI*Rank ⋔ : 1 (1, 2)
• Percent of Cases with Late Stage : 71.0

Minnesota²

• Rate : The incidence rate is 14.3 with a 95% confidence interval from 13.9 to 14.7 and 996 average annual cases over 2018-2022.
• CI*Rank ⋔ : 2 (1, 6)
• Percent of Cases with Late Stage : 64.0

Wisconsin²

• Rate : The incidence rate is 14.3 with a 95% confidence interval from 13.9 to 14.7 and 1,074 average annual cases over 2018-2022.
• CI*Rank ⋔ : 3 (1, 6)
• Percent of Cases with Late Stage : 69.5

Connecticut⁷

• Rate : The incidence rate is 13.9 with a 95% confidence interval from 13.4 to 14.4 and 648 average annual cases over 2018-2022.
• CI*Rank ⋔ : 4 (2, 12)
• Percent of Cases with Late Stage : 66.3

Maine²

• Rate : The incidence rate is 13.7 with a 95% confidence interval from 12.9 to 14.4 and 276 average annual cases over 2018-2022.
• CI*Rank ⋔ : 5 (2, 24)
• Percent of Cases with Late Stage : 70.8

Kentucky⁷

• Rate : The incidence rate is 13.6 with a 95% confidence interval from 13.1 to 14.0 and 750 average annual cases over 2018-2022.
• CI*Rank ⋔ : 6 (3, 16)
• Percent of Cases with Late Stage : 69.6

Missouri²

• Rate : The incidence rate is 13.4 with a 95% confidence interval from 13.1 to 13.8 and 1,038 average annual cases over 2018-2022.
• CI*Rank ⋔ : 7 (4, 18)
• Percent of Cases with Late Stage : 71.3

Ohio²

• Rate : The incidence rate is 13.4 with a 95% confidence interval from 13.1 to 13.6 and 1,992 average annual cases over 2018-2022.
• CI*Rank ⋔ : 8 (4, 16)
• Percent of Cases with Late Stage : 71.0

South Dakota²

• Rate : The incidence rate is 13.3 with a 95% confidence interval from 12.3 to 14.4 and 145 average annual cases over 2018-2022.
• CI*Rank ⋔ : 9 (2, 34)
• Percent of Cases with Late Stage : 69.9

West Virginia²

• Rate : The incidence rate is 13.3 with a 95% confidence interval from 12.6 to 14.0 and 336 average annual cases over 2018-2022.
• CI*Rank ⋔ : 10 (3, 29)
• Percent of Cases with Late Stage : 69.3

Vermont²

• Rate : The incidence rate is 13.1 with a 95% confidence interval from 12.1 to 14.3 and 122 average annual cases over 2018-2022.
• CI*Rank ⋔ : 11 (2, 37)
• Percent of Cases with Late Stage : 69.7

Pennsylvania²

• Rate : The incidence rate is 13.1 with a 95% confidence interval from 12.8 to 13.3 and 2,267 average annual cases over 2018-2022.
• CI*Rank ⋔ : 12 (7, 21)
• Percent of Cases with Late Stage : 69.7

New Jersey⁷

• Rate : The incidence rate is 13.0 with a 95% confidence interval from 12.7 to 13.3 and 1,488 average annual cases over 2018-2022.
• CI*Rank ⋔ : 13 (7, 24)
• Percent of Cases with Late Stage : 62.7

Idaho⁷

• Rate : The incidence rate is 13.0 with a 95% confidence interval from 12.3 to 13.7 and 285 average annual cases over 2018-2022.
• CI*Rank ⋔ : 14 (4, 33)
• Percent of Cases with Late Stage : 70.1

New York⁷

• Rate : The incidence rate is 13.0 with a 95% confidence interval from 12.7 to 13.2 and 3,214 average annual cases over 2018-2022.
• CI*Rank ⋔ : 15 (9, 23)
• Percent of Cases with Late Stage : 64.0

Rhode Island²

• Rate : The incidence rate is 12.9 with a 95% confidence interval from 12.0 to 13.8 and 182 average annual cases over 2018-2022.
• CI*Rank ⋔ : 16 (3, 36)
• Percent of Cases with Late Stage : 69.1

Indiana²

• Rate : The incidence rate is 12.8 with a 95% confidence interval from 12.5 to 13.2 and 1,035 average annual cases over 2018-2022.
• CI*Rank ⋔ : 17 (8, 29)
• Percent of Cases with Late Stage : 70.5

New Hampshire²

• Rate : The incidence rate is 12.7 with a 95% confidence interval from 12.0 to 13.5 and 241 average annual cases over 2018-2022.
• CI*Rank ⋔ : 18 (4, 36)
• Percent of Cases with Late Stage : 63.6

Illinois⁷

• Rate : The incidence rate is 12.7 with a 95% confidence interval from 12.5 to 13.0 and 1,943 average annual cases over 2018-2022.
• CI*Rank ⋔ : 19 (12, 30)
• Percent of Cases with Late Stage : 67.8

North Dakota²

• Rate : The incidence rate is 12.7 with a 95% confidence interval from 11.6 to 13.8 and 114 average annual cases over 2018-2022.
• CI*Rank ⋔ : 20 (2, 39)
• Percent of Cases with Late Stage : 68.2

Michigan²

• Rate : The incidence rate is 12.6 with a 95% confidence interval from 12.3 to 12.9 and 1,611 average annual cases over 2018-2022.
• CI*Rank ⋔ : 21 (13, 31)
• Percent of Cases with Late Stage : 67.9

Florida²

• Rate : The incidence rate is 12.6 with a 95% confidence interval from 12.4 to 12.8 and 3,820 average annual cases over 2018-2022.
• CI*Rank ⋔ : 22 (15, 30)
• Percent of Cases with Late Stage : 57.9

Louisiana⁷

• Rate : The incidence rate is 12.6 with a 95% confidence interval from 12.2 to 13.0 and 683 average annual cases over 2018-2022.
• CI*Rank ⋔ : 23 (10, 33)
• Percent of Cases with Late Stage : 67.4

North Carolina²

• Rate : The incidence rate is 12.6 with a 95% confidence interval from 12.3 to 12.8 and 1,583 average annual cases over 2018-2022.
• CI*Rank ⋔ : 24 (13, 31)
• Percent of Cases with Late Stage : 69.9

Kansas²

• Rate : The incidence rate is 12.5 with a 95% confidence interval from 12.0 to 13.1 and 436 average annual cases over 2018-2022.
• CI*Rank ⋔ : 25 (8, 35)
• Percent of Cases with Late Stage : 66.9

Montana²

• Rate : The incidence rate is 12.5 with a 95% confidence interval from 11.7 to 13.4 and 183 average annual cases over 2018-2022.
• CI*Rank ⋔ : 26 (5, 38)
• Percent of Cases with Late Stage : 72.3

Washington¹

• Rate : The incidence rate is 12.5 with a 95% confidence interval from 12.1 to 12.8 and 1,124 average annual cases over 2018-2022.
• CI*Rank ⋔ : 27 (14, 33)
• Percent of Cases with Late Stage : 66.2

Alaska²

• Rate : The incidence rate is 12.4 with a 95% confidence interval from 11.2 to 13.7 and 90 average annual cases over 2018-2022.
• CI*Rank ⋔ : 28 (3, 42)
• Percent of Cases with Late Stage : 67.6

Utah⁷

• Rate : The incidence rate is 12.4 with a 95% confidence interval from 11.8 to 13.0 and 364 average annual cases over 2018-2022.
• CI*Rank ⋔ : 29 (9, 37)
• Percent of Cases with Late Stage : 67.2

Massachusetts²

• Rate : The incidence rate is 12.3 with a 95% confidence interval from 12.0 to 12.6 and 1,081 average annual cases over 2018-2022.
• CI*Rank ⋔ : 30 (17, 35)
• Percent of Cases with Late Stage : 66.5

Nebraska²

• Rate : The incidence rate is 12.2 with a 95% confidence interval from 11.5 to 12.9 and 279 average annual cases over 2018-2022.
• CI*Rank ⋔ : 31 (10, 38)
• Percent of Cases with Late Stage : 65.4

Delaware²

• Rate : The incidence rate is 12.0 with a 95% confidence interval from 11.2 to 12.9 and 160 average annual cases over 2018-2022.
• CI*Rank ⋔ : 32 (9, 40)
• Percent of Cases with Late Stage : 68.8

California⁷

• Rate : The incidence rate is 12.0 with a 95% confidence interval from 11.8 to 12.1 and 5,326 average annual cases over 2018-2022.
• CI*Rank ⋔ : 33 (27, 35)
• Percent of Cases with Late Stage : 66.3

Georgia⁷

• Rate : The incidence rate is 11.8 with a 95% confidence interval from 11.5 to 12.1 and 1,376 average annual cases over 2018-2022.
• CI*Rank ⋔ : 34 (28, 38)
• Percent of Cases with Late Stage : 68.1

Oklahoma²

• Rate : The incidence rate is 11.7 with a 95% confidence interval from 11.2 to 12.1 and 543 average annual cases over 2018-2022.
• CI*Rank ⋔ : 35 (27, 40)
• Percent of Cases with Late Stage : 67.3

Oregon²

• Rate : The incidence rate is 11.6 with a 95% confidence interval from 11.2 to 12.1 and 628 average annual cases over 2018-2022.
• CI*Rank ⋔ : 36 (28, 40)
• Percent of Cases with Late Stage : 65.6

Maryland²

• Rate : The incidence rate is 11.6 with a 95% confidence interval from 11.3 to 12.0 and 855 average annual cases over 2018-2022.
• CI*Rank ⋔ : 37 (29, 39)
• Percent of Cases with Late Stage : 67.4

Arkansas²

• Rate : The incidence rate is 11.4 with a 95% confidence interval from 10.9 to 11.9 and 429 average annual cases over 2018-2022.
• CI*Rank ⋔ : 38 (30, 41)
• Percent of Cases with Late Stage : 64.4

Colorado²

• Rate : The incidence rate is 11.1 with a 95% confidence interval from 10.7 to 11.5 and 712 average annual cases over 2018-2022.
• CI*Rank ⋔ : 39 (35, 42)
• Percent of Cases with Late Stage : 68.4

Texas⁷

• Rate : The incidence rate is 11.0 with a 95% confidence interval from 10.9 to 11.2 and 3,277 average annual cases over 2018-2022.
• CI*Rank ⋔ : 40 (37, 41)
• Percent of Cases with Late Stage : 62.7

Tennessee²

• Rate : The incidence rate is 10.5 with a 95% confidence interval from 10.2 to 10.8 and 878 average annual cases over 2018-2022.
• CI*Rank ⋔ : 41 (39, 45)
• Percent of Cases with Late Stage : 61.5

Virginia²

• Rate : The incidence rate is 10.5 with a 95% confidence interval from 10.2 to 10.7 and 1,071 average annual cases over 2018-2022.
• CI*Rank ⋔ : 42 (40, 45)
• Percent of Cases with Late Stage : 64.8

South Carolina²

• Rate : The incidence rate is 10.4 with a 95% confidence interval from 10.0 to 10.8 and 674 average annual cases over 2018-2022.
• CI*Rank ⋔ : 43 (40, 46)
• Percent of Cases with Late Stage : 66.3

Mississippi²

• Rate : The incidence rate is 10.2 with a 95% confidence interval from 9.7 to 10.7 and 360 average annual cases over 2018-2022.
• CI*Rank ⋔ : 44 (40, 48)
• Percent of Cases with Late Stage : 63.5

Arizona²

• Rate : The incidence rate is 9.7 with a 95% confidence interval from 9.4 to 10.0 and 884 average annual cases over 2018-2022.
• CI*Rank ⋔ : 45 (44, 48)
• Percent of Cases with Late Stage : 63.6

Hawaii⁷

• Rate : The incidence rate is 9.6 with a 95% confidence interval from 9.0 to 10.3 and 188 average annual cases over 2018-2022.
• CI*Rank ⋔ : 46 (41, 49)
• Percent of Cases with Late Stage : 65.2

District of Columbia²

• Rate : The incidence rate is 9.5 with a 95% confidence interval from 8.5 to 10.6 and 64 average annual cases over 2018-2022.
• CI*Rank ⋔ : 47 (38, 51)
• Percent of Cases with Late Stage : 61.1

Wyoming²

• Rate : The incidence rate is 9.4 with a 95% confidence interval from 8.3 to 10.5 and 66 average annual cases over 2018-2022.
• CI*Rank ⋔ : 48 (40, 51)
• Percent of Cases with Late Stage : 59.1

Alabama²

• Rate : The incidence rate is 8.9 with a 95% confidence interval from 8.5 to 9.2 and 550 average annual cases over 2018-2022.
• CI*Rank ⋔ : 49 (46, 50)
• Percent of Cases with Late Stage : 62.8

New Mexico⁷

• Rate : The incidence rate is 8.2 with a 95% confidence interval from 7.7 to 8.7 and 223 average annual cases over 2018-2022.
• CI*Rank ⋔ : 50 (48, 51)
• Percent of Cases with Late Stage : 58.3

Nevada²

• Rate : The incidence rate is 8.0 with a 95% confidence interval from 7.6 to 8.5 and 296 average annual cases over 2018-2022.
• CI*Rank ⋔ : 51 (49, 51)
• Percent of Cases with Late Stage : 56.9

Puerto Rico²

• Rate : The incidence rate is 5.3 with a 95% confidence interval from 5.0 to 5.7 and 244 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : 39.5

Notes:
Created by statecancerprofiles.cancer.gov on 02/18/2026 4:26 pm.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. The rates used in CI*Rank are all age-adjusted to the 2000 US standard population using 19 age groups for SEER and NPCR areas. More information about methodology can be found on the CI*Rank website.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.

CI*Rank data for Puerto Rico is not available.